Cas:67159-85-7 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one manufacturer & supplier

Chemical Name:5-bromo-2,3-dihydro-3,3-dimethylinden-1-one

CAS.NO:67159-85-7

Synonyms:5-bromo-2,3-dihydro-3,3-dimethylinden-1-one

Molecular Formula:C₁₁H₁₁BrO

Molecular Weight:239.10844

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-2,3-dihydro-3,3-dimethylinden-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-2,3-dihydro-3,3-dimethylinden-1-one Use and application,5-bromo-2,3-dihydro-3,3-dimethylinden-1-one technical grade,usp/ep/jp grade.

Related News: On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one manufacturer Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one vendor ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 5-bromo-2,3-dihydro-3,3-dimethylinden-1-one factory Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue.